Indaptus Therapeutics, Inc.
INDP
$2.52
$0.4421.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.79M | -2.54M | -8.11M | -2.98M | -5.23M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.30K | 637.30K | 785.80K | 516.30K | 968.50K |
| Change in Net Operating Assets | -68.50K | -5.11M | 4.14M | -108.60K | 242.30K |
| Cash from Operations | -1.93M | -7.01M | -3.19M | -2.57M | -4.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00M | -- | -- | -- | -- |
| Cash from Investing | -4.00M | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 5.71M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.00M | -- | 1.80K | 2.34M | 575.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 6.00M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.20K | -- | -129.30K | -104.00K | -5.00K |
| Cash from Financing | 11.98M | -- | 5.87M | 2.24M | 6.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.06M | -7.01M | 2.68M | -332.10K | 2.27M |